{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:33:08Z","timestamp":1794353588921,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer stem cells (CSCs) drive tumor progression through poorly understood metabolic-epigenetic crosstalk. Here, we identify mitochondrial RNA polymerase POLRMT as a key link connecting mitochondrial transcription to CSC maintenance. Clinically, POLRMT is overexpressed in colorectal cancer (CRC) tissues and correlates with poor prognosis. Genetic ablation or pharmacological inhibition of POLRMT suppresses CSC self-renewal and tumorigenicity across cell line-derived CSCs, CRC organoids, and xenograft models. Mechanistically, POLRMT deficiency triggers mitochondrial dysfunction, which unexpectedly elevates the demethylase KDM6B expression, \u03b1-ketoglutarate (\u03b1-KG) levels, and Dickkopf-1 (DKK1) expression, thereby transcriptionally silencing Wnt\/\u03b2-catenin signaling and collapsing the CSC niche. Restoration of \u03b2-catenin rescues tumorigenicity in POLRMT-knockout (KO) cells, confirming the hierarchy of this signaling cascade. Crucially, POLRMT catalytic activity and mitochondrial localization are indispensable for sustaining this axis. Our work unveils POLRMT as a metabolic gatekeeper that licenses CSC plasticity through KDM6B\u2013\u03b1-KG\/H3K27me3-mediated chromatin remodeling, proposing the mitochondrial transcription machinery as a therapeutic target for dismantling the CSC hierarchy in CRC.<\/jats:p>","DOI":"10.1038\/s41418-026-01807-5","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:29:23Z","timestamp":1784096963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting POLRMT-driven epigenetic remodeling of Wnt\/\u03b2-catenin to eradicate colorectal cancer stem cell proliferation"],"prefix":"10.1038","author":[{"given":"Lei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-9369","authenticated-orcid":false,"given":"Ran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6919-2034","authenticated-orcid":false,"given":"Shaoxing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-8265","authenticated-orcid":false,"given":"Jihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"1807_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1807_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1486653","volume":"14","author":"F Giovinazzo","year":"2024","unstructured":"Giovinazzo F, Gallo G, Goglia M, Pavone M, Coppola A, Dell\u2019Aquila E. Editorial: future frontiers in the management of metastatic colorectal cancer. Front Oncol. 2024;14:1486653.","journal-title":"Front Oncol"},{"key":"1807_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103920","volume":"182","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N, Afshinpour M, Fakhr SS, Kalkhoran PG, Shadman-Manesh V, Adelian S, et al. Cancer stem cells in colorectal cancer: signaling pathways involved in stemness and therapy resistance. Crit Rev Oncol Hematol. 2023;182:103920.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1807_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124\u201334.","journal-title":"Nat Med"},{"key":"1807_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi C, Taddei ML, Sacco E, Navari N, Correnti M, Piombanti B, et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J Hepatol. 2021;74:1373\u201385.","journal-title":"J Hepatol"},{"key":"1807_CR6","doi-asserted-by":"crossref","unstructured":"Yu Q, Jiang K, Ma S, Zheng Q, Tondi S, Reina C, et al. Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in pancreatic ductal adenocarcinoma. Mol Ther; 2025;33:6160-77.","DOI":"10.1016\/j.ymthe.2025.09.004"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fphar.2019.00203","volume":"10","author":"P Jagust","year":"2019","unstructured":"Jagust P, de Lux\u00e1n-Delgado B, Parejo-Alonso B, Sancho P. Metabolism-based therapeutic strategies targeting cancer stem cells. Front Pharmacol. 2019;10:203.","journal-title":"Front Pharmacol"},{"key":"1807_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41420-024-01926-3","volume":"10","author":"T Lei","year":"2024","unstructured":"Lei T, Rui Y, Xiaoshuang Z, Jinglan Z, Jihong Z. Mitochondria transcription and cancer. Cell Death Discov. 2024;10:168.","journal-title":"Cell Death Discov"},{"key":"1807_CR10","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.molcel.2025.06.016","volume":"85","author":"K Herbine","year":"2025","unstructured":"Herbine K, Nayak AR, Zamudio-Ochoa A, Temiakov D. Structural basis for promoter recognition and transcription factor binding and release in human mitochondria. Mol Cell. 2025;85:3123\u201336.e7.","journal-title":"Mol Cell"},{"key":"1807_CR11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s44318-024-00101-9","volume":"43","author":"W Yan","year":"2024","unstructured":"Yan W, Xie C, Sun S, Zheng Q, Wang J, Wang Z, et al. SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression. Embo J. 2024;43:2337\u201367.","journal-title":"Embo J"},{"key":"1807_CR12","doi-asserted-by":"publisher","first-page":"37216","DOI":"10.18632\/oncotarget.6129","volume":"6","author":"FN Bralha","year":"2015","unstructured":"Bralha FN, Liyanage SU, Hurren R, Wang X, Son MH, Fung TA, et al. Targeting mitochondrial RNA polymerase in acute myeloid leukemia. Oncotarget. 2015;6:37216\u201328.","journal-title":"Oncotarget"},{"key":"1807_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41420-021-00780-x","volume":"7","author":"QC Han","year":"2021","unstructured":"Han QC, Zhang XY, Yan PH, Chen SF, Liu FF, Zhu YR, et al. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma. Cell Death Discov. 2021;7:393.","journal-title":"Cell Death Discov"},{"key":"1807_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06444-9","volume":"15","author":"Y Kong","year":"2024","unstructured":"Kong Y, Li X, Zhang H, Fu B, Jiang HY, Yang HL, et al. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo. Cell Death Dis. 2024;15:57.","journal-title":"Cell Death Dis"},{"key":"1807_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05682-7","volume":"14","author":"SP Li","year":"2023","unstructured":"Li SP, Ou L, Zhang Y, Shen FR, Chen YG. A first-in-class POLRMT-specific inhibitor IMT1 suppresses endometrial carcinoma cell growth. Cell Death Dis. 2023;14:152.","journal-title":"Cell Death Dis"},{"key":"1807_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06203-2","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Yao L, Wang T, Gu X, Wu Y, Jiang T. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. Cell Death Dis. 2023;14:665.","journal-title":"Cell Death Dis"},{"key":"1807_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41420-022-01148-5","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ou L, Li X, Zheng T, Zhu WP, Li P, et al. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth. Cell Death Discov. 2022;8:347.","journal-title":"Cell Death Discov"},{"key":"1807_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04039-2","volume":"12","author":"T Zhou","year":"2021","unstructured":"Zhou T, Sang YH, Cai S, Xu C, Shi MH. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth. Cell Death Dis. 2021;12:751.","journal-title":"Cell Death Dis"},{"key":"1807_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/j.gastro.2015.06.007","volume":"149","author":"IS Song","year":"2015","unstructured":"Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, et al. FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function. Gastroenterology. 2015;149:1006\u201316.e9.","journal-title":"Gastroenterology"},{"key":"1807_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.582694","volume":"11","author":"Y Iranmanesh","year":"2021","unstructured":"Iranmanesh Y, Jiang B, Favour OC, Dou Z, Wu J, Li J, et al. Mitochondria\u2019s role in the maintenance of cancer stem cells in glioblastoma. Front Oncol. 2021;11:582694.","journal-title":"Front Oncol"},{"key":"1807_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ijc.25944","volume":"129","author":"XQ Ye","year":"2011","unstructured":"Ye XQ, Li Q, Wang GH, Sun FF, Huang GJ, Bian XW, et al. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int J Cancer. 2011;129:820\u201331.","journal-title":"Int J Cancer"},{"key":"1807_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-020-03048-z","volume":"588","author":"NA Bonekamp","year":"2020","unstructured":"Bonekamp NA, Peter B, Hillen HS, Felser A, Bergbrede T, Choidas A, et al. Small-molecule inhibitors of human mitochondrial DNA transcription. Nature. 2020;588:712\u20136.","journal-title":"Nature"},{"key":"1807_CR23","doi-asserted-by":"crossref","unstructured":"Daglish SCD, Fennell EMJ, Graves LM. Targeting mitochondrial DNA transcription by POLRMT inhibition or depletion as a potential strategy for cancer treatment. Biomedicines. 2023;11:1598.","DOI":"10.3390\/biomedicines11061598"},{"key":"1807_CR24","doi-asserted-by":"crossref","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622.","DOI":"10.3390\/ijms22052622"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"HO Lee","year":"2020","unstructured":"Lee HO, Hong Y, Etlioglu HE, Cho YB, Pomella V, Van den Bosch B, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52:594\u2013603.","journal-title":"Nat Genet"},{"key":"1807_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217452","volume":"612","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Sun D, Gao J, Gao Q, Lv Y, Du T, et al. Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence. Cancer Lett. 2025;612:217452.","journal-title":"Cancer Lett"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2017.10.036","volume":"171","author":"HS Hillen","year":"2017","unstructured":"Hillen HS, Morozov YI, Sarfallah A, Temiakov D, Cramer P. Structural basis of mitochondrial transcription initiation. Cell. 2017;171:1072\u201381.e10.","journal-title":"Cell"},{"key":"1807_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21279-0","volume":"12","author":"M Ol\u00e1hov\u00e1","year":"2021","unstructured":"Ol\u00e1hov\u00e1 M, Peter B, Szilagyi Z, Diaz-Maldonado H, Singh M, Sommerville EW, et al. POLRMT mutations impair mitochondrial transcription, causing neurological disease. Nat Commun. 2021;12:1135.","journal-title":"Nat Commun"},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s43018-020-0035-5","volume":"1","author":"TQ Tran","year":"2020","unstructured":"Tran TQ, Hanse EA, Habowski AN, Li H, Ishak Gabra MB, Yang Y, et al. \u03b1-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nat Cancer. 2020;1:345\u201358.","journal-title":"Nat Cancer"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1158\/1078-0432.CCR-16-2506","volume":"23","author":"TQ Tran","year":"2017","unstructured":"Tran TQ, Lowman XH, Kong M. Molecular pathways: metabolic control of histone methylation and gene expression in cancer. Clin Cancer Res. 2017;23:4004\u20139.","journal-title":"Clin Cancer Res"},{"key":"1807_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/cr.2012.119","volume":"23","author":"W Jiang","year":"2013","unstructured":"Jiang W, Wang J, Zhang Y. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway. Cell Res. 2013;23:122\u201330.","journal-title":"Cell Res"},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16:19\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1807_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2018.08.001","volume":"28","author":"AJM Santos","year":"2018","unstructured":"Santos AJM, Lo YH, Mah AT, Kuo CJ. The intestinal stem cell niche: homeostasis and adaptations. Trends Cell Biol. 2018;28:1062\u201378.","journal-title":"Trends Cell Biol"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608\u201311.","journal-title":"Nature"},{"key":"1807_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2017.06.012","volume":"47","author":"R Loureiro","year":"2017","unstructured":"Loureiro R, Mesquita KA, Magalh\u00e3es-Novais S, Oliveira PJ, Vega-Naredo I. Mitochondrial biology in cancer stem cells. Semin Cancer Biol. 2017;47:18\u201328.","journal-title":"Semin Cancer Biol"},{"key":"1807_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0712-6","volume":"18","author":"M Peiris-Pag\u00e8s","year":"2016","unstructured":"Peiris-Pag\u00e8s M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Res. 2016;18:55.","journal-title":"Breast Cancer Res"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"30472","DOI":"10.18632\/oncotarget.5401","volume":"6","author":"G Farnie","year":"2015","unstructured":"Farnie G, Sotgia F, Lisanti MP. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget. 2015;6:30472\u201386.","journal-title":"Oncotarget"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-018-0011-z","volume":"3","author":"X Sun","year":"2018","unstructured":"Sun X, Zhan L, Chen Y, Wang G, He L, Wang Q, et al. Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer. Signal Transduct Target Ther. 2018;3:8.","journal-title":"Signal Transduct Target Ther"},{"key":"1807_CR39","doi-asserted-by":"crossref","unstructured":"Fattore L, Mancini R, Ciliberto G. Cancer stem cells and the slow cycling phenotype: how to cut the Gordian knot driving resistance to therapy in melanoma. Cancers. 2020;12:3368.","DOI":"10.3390\/cancers12113368"},{"key":"1807_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39640-w","volume":"14","author":"A Erazo-Oliveras","year":"2023","unstructured":"Erazo-Oliveras A, Mu\u00f1oz-Vega M, Mlih M, Thiriveedi V, Salinas ML, Rivera-Rodr\u00edguez JM, et al. Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic \u03b2-catenin. Nat Commun. 2023;14:4342.","journal-title":"Nat Commun"},{"key":"1807_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"key":"1807_CR42","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/thno.53347","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Li F, Gao B, Ma M, Chen M, Wu Y, et al. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma. Theranostics. 2021;11:3868\u201381.","journal-title":"Theranostics"},{"key":"1807_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101056","volume":"4","author":"S Radenkovic","year":"2023","unstructured":"Radenkovic S, Ligezka AN, Mokashi SS, Driesen K, Dukes-Rimsky L, Preston G, et al. Tracer metabolomics reveals the role of aldose reductase in glycosylation. Cell Rep Med. 2023;4:101056.","journal-title":"Cell Rep Med"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01807-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:29:25Z","timestamp":1784096965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":43,"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01807-5","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Human organoid experiments were approved by the Renji Hospital Ethics Committee of Shanghai Jiaotong University School of Medicine (Approval No. KY2024-126-B). The staining experiments using human tumor tissue specimens were conducted in accordance with the ethical guidelines of the Institutional Review Board of Nanjing Medical University and were approved by the Ethics Committee of the Cancer Institute of Jiangsu Province (Approval No. SHYJS-CP-1910008). Written informed consent was obtained from all participants prior to tissue collection. All murine experiments were approved by the Institutional Animal Care and Treatment Committee of Kunming University of Science and Technology (Approval No. PZWH (Dian) K2021-0013, issued on March 8, 2021).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}